Otezla Now Approved for All Severity Levels of Psoriasis | MyPsoriasisTeam

Connect with others who understand.

sign up log in
Resources
About MyPsoriasisTeam
Powered By
PSORIASIS
NEWS

Otezla Now Approved for All Severity Levels of Psoriasis

Medically reviewed by Ariel D. Teitel, M.D., M.B.A. — Written by Maureen McNulty
Posted on January 12, 2022
(Adobe Stock)

  • The U.S. Food and Drug Administration (FDA) recently approved a new use for Otezla (apremilast).
  • Apremilast can now be used to treat mild to moderate plaque psoriasis, making it the only drug currently approved for all severity levels of psoriasis.
  • A clinical trial found that apremilast improved psoriasis signs and symptoms in people with milder disease cases.

The FDA recently approved Otezla as a treatment for adults with mild to moderate plaque psoriasis who are eligible to receive phototherapy (light treatments) or systemic therapy (medications that travel throughout the bloodstream). The decision was announced on Dec. 20.

Otezla was originally approved in March 2014 to treat psoriatic arthritis. A few months later, the FDA approved the drug as a treatment option for people with moderate to severe plaque psoriasis.

This expanded approval is good news for people with milder cases of psoriasis, according to Dr. David M. Reese, executive vice president of research and development at Amgen — the company that makes Otezla.

“A substantial unmet need remains for mild to moderate plaque psoriasis patients for whom topical therapies may not be sufficient, especially for those with difficult-to-treat areas, like the scalp,” said Dr. Reese in a recent press release. “With this expanded indication for Otezla, patients across all levels of disease severity now have an oral, systemic option that has already been used by more than 650,000 people worldwide.”

Is Otezla Effective?

Otezla’s new approval came after Amgen reported positive results from its phase 3 ADVANCE trial, which measured safety and effectiveness of the drug in people with mild or moderate psoriasis. There have been a few key findings from this trial so far:

  • People who took apremilast were five times more likely to have less severe disease after four months of therapy, compared to people who took a placebo (sugar pill).
  • Those who used apremilast were more likely to have smaller areas of their skin affected by psoriasis plaques and were less likely to have an affected scalp.
  • People using apremilast had improved symptoms, such as less itching.

This trial also showed that apremilast is safe. Researchers identified a few potential side effects, including headache, nausea, diarrhea, and cold symptoms.

Posted on January 12, 2022
All updates must be accompanied by text or a picture.

Become a Subscriber

Get the latest news about psoriasis sent to your inbox.

Ariel D. Teitel, M.D., M.B.A. is the clinical associate professor of medicine at the NYU Langone Medical Center in New York. Review provided by VeriMed Healthcare Network. Learn more about him here.
Maureen McNulty studied molecular genetics and English at Ohio State University. Learn more about her here.

Recent articles

My psoriasis journey started when I was a child, about 10. I had severe psoriasis on my hands, bu...

From Spondylitis to Osteoarthritis: How Psoriasis Affects My Joints

My psoriasis journey started when I was a child, about 10. I had severe psoriasis on my hands, bu...
Living with psoriasis can be an emotional roller coaster. This condition affects not only the phy...

How I Navigate the Emotional Ups and Downs of Psoriasis

Living with psoriasis can be an emotional roller coaster. This condition affects not only the phy...
There used to be a commercial that decried “the heartbreak of psoriasis.” It was so ubiquitous th...

What I’ve Learned After Living With Psoriasis for 50 Years

There used to be a commercial that decried “the heartbreak of psoriasis.” It was so ubiquitous th...
Arthritis mutilans is the most severe form of psoriatic arthritis (PsA). About 5 percent of peopl...

Psoriatic Arthritis Mutilans: The Most Severe Form of PsA

Arthritis mutilans is the most severe form of psoriatic arthritis (PsA). About 5 percent of peopl...
Watch Miriam’s video to learn how psoriasis is a guiding light for taking care of herself and con...

How I’ve Become My Healthiest Self With Psoriasis

Watch Miriam’s video to learn how psoriasis is a guiding light for taking care of herself and con...
The nose knows. Or does it? While this vital organ can tell you if someone is baking your favorit...

Psoriasis in the Nose: 5 Facts To Know

The nose knows. Or does it? While this vital organ can tell you if someone is baking your favorit...
psoriasis News
psoriasis News

Thank you for subscribing!

Become a member to get even more:

sign up for free

close